Synopsys, Inc. $SNPS Stock Position Raised by Kinsale Capital Group Inc.

Kinsale Capital Group Inc. raised its holdings in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 26.7% in the third quarter, according to the company in its most recent disclosure with the SEC. The fund owned 29,484 shares of the semiconductor company’s stock after buying an additional 6,214 shares during the quarter. Synopsys comprises 1.7% of Kinsale Capital Group Inc.’s holdings, making the stock its 22nd largest position. Kinsale Capital Group Inc.’s holdings in Synopsys were worth $12,824,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in the business. 71 West Capital Partners boosted its stake in Synopsys by 5.5% in the 3rd quarter. 71 West Capital Partners now owns 1,206 shares of the semiconductor company’s stock worth $525,000 after purchasing an additional 63 shares in the last quarter. Fulcrum Asset Management LLP raised its holdings in shares of Synopsys by 55.8% in the third quarter. Fulcrum Asset Management LLP now owns 8,705 shares of the semiconductor company’s stock worth $3,613,000 after buying an additional 3,118 shares during the last quarter. Kornitzer Capital Management Inc. KS raised its holdings in shares of Synopsys by 96.7% in the third quarter. Kornitzer Capital Management Inc. KS now owns 3,979 shares of the semiconductor company’s stock worth $1,731,000 after buying an additional 1,956 shares during the last quarter. Pictet Asset Management Holding SA raised its holdings in shares of Synopsys by 90.8% in the third quarter. Pictet Asset Management Holding SA now owns 1,132,130 shares of the semiconductor company’s stock worth $492,223,000 after buying an additional 538,737 shares during the last quarter. Finally, Formidable Asset Management LLC lifted its stake in shares of Synopsys by 133.3% during the third quarter. Formidable Asset Management LLC now owns 4,153 shares of the semiconductor company’s stock worth $1,833,000 after buying an additional 2,373 shares during the period. Institutional investors and hedge funds own 85.47% of the company’s stock.

Insider Buying and Selling at Synopsys

In other Synopsys news, CEO Sassine Ghazi sold 14,604 shares of the stock in a transaction dated Thursday, October 15th. The stock was sold at an average price of $462.84, for a total transaction of $6,759,315.36. Following the sale, the chief executive officer directly owned 76,865 shares of the company’s stock, valued at approximately $35,576,196.60. This trade represents a 15.97% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Aart de Geus sold 24,641 shares of Synopsys stock in a transaction dated Tuesday, September 1st. The shares were sold at an average price of $419.44, for a total value of $10,335,421.04. Following the transaction, the insider owned 120,443 shares of the company’s stock, valued at $50,518,611.92. The trade was a 16.98% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 117,163 shares of company stock valued at $51,366,457 in the last three months. Company insiders own 0.56% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on the stock. Morgan Stanley boosted their price objective on shares of Synopsys from $500.00 to $574.00 and gave the company an “overweight” rating in a report on Tuesday, October 20th. Barclays began coverage on Synopsys in a research note on Friday, September 25th. They issued an “overweight” rating for the company. KeyCorp lifted their price target on Synopsys from $600.00 to $605.00 and gave the stock an “overweight” rating in a research report on Thursday, October 1st. Weiss Ratings downgraded Synopsys from a “hold (c)” rating to a “hold (c-)” rating in a research note on Friday, September 11th. Finally, Rothschild & Co Redburn cut their price objective on Synopsys from $560.00 to $550.00 and set a “buy” rating on the stock in a report on Wednesday, September 23rd. One investment analyst has rated the stock with a Strong Buy rating, twenty-two have issued a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, Synopsys currently has an average rating of “Moderate Buy” and a consensus target price of $575.00.

Read Our Latest Report on Synopsys

Synopsys Stock Performance

Shares of NASDAQ SNPS opened at $466.97 on Tuesday. The company has a 50 day simple moving average of $442.10 and a two-hundred day simple moving average of $442.00. The stock has a market cap of $89.49 billion, a price-to-earnings ratio of 82.50, a PEG ratio of 1.47 and a beta of 1.18. The company has a current ratio of 1.34, a quick ratio of 1.24 and a debt-to-equity ratio of 0.29. Synopsys, Inc. has a 12 month low of $362.55 and a 12 month high of $539.48.

Synopsys (NASDAQ:SNPS – Get Free Report) last released its quarterly earnings data on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share for the quarter, topping analysts’ consensus estimates of $3.67 by $0.24. Synopsys had a net margin of 11.43% and a return on equity of 6.24%. The firm had revenue of $2.48 billion for the quarter, compared to analyst estimates of $2.44 billion. During the same quarter in the prior year, the business earned $3.39 earnings per share. The business’s quarterly revenue was up 42.4% compared to the same quarter last year. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. As a group, analysts predict that Synopsys, Inc. will post 11.01 earnings per share for the current year.

Synopsys declared that its Board of Directors has initiated a share buyback plan on Monday, October 5th that authorizes the company to repurchase $1 billion in shares. This repurchase authorization authorizes the semiconductor company to repurchase up to 1.1% of its shares through open market purchases. Share repurchase plans are often an indication that the company’s board of directors believes its shares are undervalued.

Synopsys Company Profile

(Free Report)

Synopsys, Inc develops software, semiconductor intellectual property (IP) and services used to design and verify electronic systems. Its electronic design automation (EDA) tools help customers create, simulate, test and validate chips and other complex electronic products, while its IP portfolio provides reusable building blocks for semiconductor designs.

The company also offers software security and quality tools that help developers identify vulnerabilities and assess applications throughout the software development process.

Read More

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.